Li et al. utilized the cyclic GMP-AMP (cGAMP) synthase (cGAS) antagonist A151 in a stroke mouse model and identified a significant neuroprotective effect through the reduction in infarct size, attenuation of cell death, and amelioration of the overall inflammatory response [89]. The gene discussed is CGAS; the disease is stroke disorder.